-
1.
公开(公告)号:US20050164234A1
公开(公告)日:2005-07-28
申请号:US10943194
申请日:2004-09-16
申请人: Stanley Crooke , Walter Lima , Hongjiang Wu
发明人: Stanley Crooke , Walter Lima , Hongjiang Wu
IPC分类号: A61P1/16 , A61P27/02 , A61P29/00 , A61P31/00 , A61P31/14 , A61P31/18 , A61P35/00 , A61P43/00 , C12N5/22 , C12N9/22 , C12N15/12 , C12P19/34 , C12Q20060101 , C12Q1/68
CPC分类号: C12N9/22 , C12N15/1137 , C12N2310/11 , C12N2310/14 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , C12P19/34 , C12Y301/26004 , G01N2333/922 , C12N2310/3525
摘要: The present invention relates to methods for using mammalian RNase H, including human RNase H, and compositions thereof, particularly for reduction of a selected cellular RNA target via antisense technology. Methods and uses for increasing or decreasing RNase H levels and activity in cells and animals are disclosed.
摘要翻译: 本发明涉及使用哺乳动物核糖核酸酶H(包括人核糖核酸酶H)及其组合物的方法,特别是通过反义技术还原所选择的细胞RNA靶。 公开了用于增加或降低细胞和动物中的RNase H水平和活性的方法和用途。
-
2.
公开(公告)号:US20050153921A1
公开(公告)日:2005-07-14
申请号:US11001386
申请日:2004-12-01
申请人: Brett Monia , Phillip Cook , Stanley Crooke , Walter Lima , Hongjiang Wu
发明人: Brett Monia , Phillip Cook , Stanley Crooke , Walter Lima , Hongjiang Wu
CPC分类号: C12N15/113 , A61K38/00 , C07H21/00 , C12N9/22 , C12N15/1135 , C12N15/1137 , C12N2310/315 , C12N2310/32 , C12N2310/321 , C12N2310/3341 , C12N2310/346 , C12N2310/3521 , C12N2310/3531 , C12Q1/6813 , C12Q1/6816 , C12Q1/6832 , C12Q2525/125 , C12Y301/26004 , C12Q2521/319 , C12Q2525/101 , C12N2310/3525
摘要: The present invention relates to methods for using mammalian RNase H and compositions thereof, particularly for reduction of a selected cellular RNA target via antisense technology.
摘要翻译: 本发明涉及使用哺乳动物核糖核酸酶H及其组合物的方法,特别是通过反义技术还原所选择的细胞RNA靶。
-
公开(公告)号:US20070292875A1
公开(公告)日:2007-12-20
申请号:US11726598
申请日:2007-03-21
申请人: Stanley Crooke , Walter Lima , Hongjiang Wu , Muthiah Monoharan
发明人: Stanley Crooke , Walter Lima , Hongjiang Wu , Muthiah Monoharan
CPC分类号: C12N15/113 , C07H21/00 , C07K2319/00 , C12N9/22 , C12N2310/31 , C12N2310/32 , C12N2310/321 , C12N2310/322 , C12N2310/3341 , C12N2310/346 , C12N2310/3525 , C12N2310/3521
摘要: The present invention provides oligonucleotides that can serve as substrates for human Type 2 RNase H. The present invention is also directed to methods of using these oligonucleotides in enhancing antisense oligonucleotide therapies.
摘要翻译: 本发明提供可用作人2型核糖核酸酶H的底物的寡核苷酸。本发明还涉及在增强反义寡核苷酸疗法中使用这些寡核苷酸的方法。
-
公开(公告)号:US20050153340A1
公开(公告)日:2005-07-14
申请号:US11005069
申请日:2004-12-06
申请人: Stanley Crooke , Walter Lima , Hongjiang Wu
发明人: Stanley Crooke , Walter Lima , Hongjiang Wu
IPC分类号: A61K38/00 , C12N9/22 , C12N15/113 , C12Q1/68 , C07H21/04
CPC分类号: C12N15/113 , A61K38/00 , C12N9/22 , C12N15/1137 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/346 , C12Y301/26004 , C12N2310/3525
摘要: The present invention relates to methods for using mammalian RNase H, including human RNase H, and compositions thereof, particularly for reduction of a selected cellular RNA target via antisense technology. A novel human RNAse HII polypeptide and the polynucleotide sequence encoding it are also disclosed.
摘要翻译: 本发明涉及使用哺乳动物核糖核酸酶H(包括人核糖核酸酶H)及其组合物的方法,特别是通过反义技术还原所选择的细胞RNA靶。 还公开了一种新的人类RNAse HII多肽和编码它的多核苷酸序列。
-
公开(公告)号:US5582972A
公开(公告)日:1996-12-10
申请号:US990303
申请日:1992-12-14
申请人: Walter Lima , Brett Monia , Susan Freier , David Ecker
发明人: Walter Lima , Brett Monia , Susan Freier , David Ecker
IPC分类号: A61K31/70 , A61K38/00 , A61K48/00 , C07K14/82 , C12N9/02 , C12N15/09 , C12N15/113 , C12N15/12 , C12Q1/68 , C12N15/10
CPC分类号: C12N15/1135 , C07K14/82 , C12N9/0069 , C12Q1/6886 , A61K38/00 , C07K2319/00 , C07K2319/61 , C12N2310/315 , C12N2310/321 , C12N2310/322 , C12N2310/333 , C12N2310/3521 , C12N2310/3527 , C12N2310/3533 , C12N2310/3535 , C12Q2600/156
摘要: Methods are provided for preparing antisense oligonucleotides which take advantage of RNA secondary and tertiary structure and for preparing antisense oligonucleotides which specifically hybridize to regions of RNA secondary and tertiary structure by comparing the affinity of the oligonucleotide for a structured RNA target to the affinity of the oligonucleotide for a length-matched oligonucleotide complement, and selecting an oligonucleotide having an affinity for the structured target which is not less than one thousandth of its affinity for the length-matched oligonucleotide complement. Oligonucleotides are also disclosed which are specifically hybridizable with regions of H-ras RNA having secondary and tertiary structure.
摘要翻译: 提供了制备反义寡核苷酸的方法,该反义寡核苷酸利用RNA二级结构和三级结构,并制备与RNA二级结构和三级结构区域特异性杂交的反义寡核苷酸,通过比较结构化RNA靶标的寡核苷酸与寡核苷酸的亲和力 对于长度匹配的寡核苷酸补体,并选择对结构化靶具有亲和力的寡核苷酸,其对于长度匹配的寡核苷酸补体不小于其亲和力的千分之一。 还公开了与具有二级和三级结构的H-ras RNA的区域特异性杂交的寡核苷酸。
-
-
-
-